NR 567 FINAL EXAM 2025/2026 Advanced Pharmacology for the AGACNP
TABLE OF CONTENTS
| Section | Topic | Questions |
|---------|-------|-----------|
| 1 | Pharmacokinetics & Pharmacodynamics | 1–25 |
| 2 | Neuropharmacology & Antiseizure Drugs | 26–55 |
| 3 | Psychopharmacology | 56–80 |
| 4 | Cardiovascular Pharmacology | 81–120 |
| 5 | Anticoagulants, Antiplatelets & Thrombolytics | 121–145 |
| 6 | Endocrine Pharmacology (Thyroid, Diabetes, Corticosteroids) | 146–175 |
| 7 | Infectious Disease & Antimicrobial Stewardship | 176–210 |
| 8 | Pain Management & Opioids | 211–235 |
| 9 | Renal & Electrolyte Pharmacology | 236–255 |
| 10 | Emergency & Critical Care Pharmacology | 256–280 |
| 11 | Geriatrics, Polypharmacy & Special Populations | 281–300 |
---
EXAM OVERVIEW
Course: NR 567 Advanced Pharmacology for the AGACNP
Exam: Final Examination
Academic Year: 2025/2026
,Institution: Chamberlain University
Format: 300 Multiple-Choice Questions
Time Limit: 4 hours (estimated)
Question Types: Clinical application, pharmacotherapy selection, mechanism of action, adverse
effects, drug interactions, and Next Generation NCLEX (NGN)-style case-based questions
Topics Covered: All core domains of advanced pharmacology for the Adult-Gerontology Acute
Care Nurse Practitioner (AGACNP), including pharmacokinetics/pharmacodynamics,
neuropharmacology, cardiovascular pharmacology, endocrine pharmacology, infectious disease,
pain management, emergency pharmacology, and special population considerations
---
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Questions 1–25)
---
Question 1
Which of the following best describes the first-pass effect?
A) The process by which a medication is excreted by the kidneys
B) The inactivation of a medication by liver enzymes after absorption from the gastrointestinal
tract
C) The binding of a medication to plasma proteins
D) The distribution of a medication from the bloodstream to tissues
Correct Answer: B
Rationale: The first-pass effect refers to the metabolism of a medication by the liver after
absorption from the gastrointestinal tract, before it reaches systemic circulation. This can
significantly reduce the bioavailability of orally administered drugs.
,---
Question 2
A patient has a medication with a half-life of 4 hours. Approximately how long will it take for the
drug to reach steady-state concentration?
A) 8 hours
B) 12 hours
C) 20 hours
D) 40 hours
Correct Answer: C
Rationale: Steady-state concentration is typically reached after approximately 4–5 half-lives.
With a half-life of 4 hours, steady-state would be achieved in approximately 20 hours (4 hours ×
5 half-lives).
---
Question 3
Which of the following factors would most significantly increase the volume of distribution of a
lipophilic drug?
A) Decreased cardiac output
B) Increased adipose tissue
C) Decreased renal function
D) Increased protein binding
Correct Answer: B
, Rationale: Lipophilic drugs distribute extensively into adipose tissue. Increased adipose tissue
provides a larger reservoir for drug storage, thereby increasing the volume of distribution.
---
Question 4
A patient with hepatic cirrhosis is prescribed a medication that undergoes extensive first-pass
metabolism. What adjustment is most appropriate?
A) Increase the dose
B) Decrease the dose
C) No dose adjustment is needed
D) Change to a topical formulation
Correct Answer: B
Rationale: Hepatic cirrhosis reduces liver function and first-pass metabolism. A lower dose is
required to achieve therapeutic drug levels and avoid toxicity.
---
Question 5
Which of the following drug classes primarily undergoes renal elimination?
A) Benzodiazepines
B) Aminoglycosides
C) Beta-blockers
D) Calcium channel blockers
Correct Answer: B
TABLE OF CONTENTS
| Section | Topic | Questions |
|---------|-------|-----------|
| 1 | Pharmacokinetics & Pharmacodynamics | 1–25 |
| 2 | Neuropharmacology & Antiseizure Drugs | 26–55 |
| 3 | Psychopharmacology | 56–80 |
| 4 | Cardiovascular Pharmacology | 81–120 |
| 5 | Anticoagulants, Antiplatelets & Thrombolytics | 121–145 |
| 6 | Endocrine Pharmacology (Thyroid, Diabetes, Corticosteroids) | 146–175 |
| 7 | Infectious Disease & Antimicrobial Stewardship | 176–210 |
| 8 | Pain Management & Opioids | 211–235 |
| 9 | Renal & Electrolyte Pharmacology | 236–255 |
| 10 | Emergency & Critical Care Pharmacology | 256–280 |
| 11 | Geriatrics, Polypharmacy & Special Populations | 281–300 |
---
EXAM OVERVIEW
Course: NR 567 Advanced Pharmacology for the AGACNP
Exam: Final Examination
Academic Year: 2025/2026
,Institution: Chamberlain University
Format: 300 Multiple-Choice Questions
Time Limit: 4 hours (estimated)
Question Types: Clinical application, pharmacotherapy selection, mechanism of action, adverse
effects, drug interactions, and Next Generation NCLEX (NGN)-style case-based questions
Topics Covered: All core domains of advanced pharmacology for the Adult-Gerontology Acute
Care Nurse Practitioner (AGACNP), including pharmacokinetics/pharmacodynamics,
neuropharmacology, cardiovascular pharmacology, endocrine pharmacology, infectious disease,
pain management, emergency pharmacology, and special population considerations
---
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Questions 1–25)
---
Question 1
Which of the following best describes the first-pass effect?
A) The process by which a medication is excreted by the kidneys
B) The inactivation of a medication by liver enzymes after absorption from the gastrointestinal
tract
C) The binding of a medication to plasma proteins
D) The distribution of a medication from the bloodstream to tissues
Correct Answer: B
Rationale: The first-pass effect refers to the metabolism of a medication by the liver after
absorption from the gastrointestinal tract, before it reaches systemic circulation. This can
significantly reduce the bioavailability of orally administered drugs.
,---
Question 2
A patient has a medication with a half-life of 4 hours. Approximately how long will it take for the
drug to reach steady-state concentration?
A) 8 hours
B) 12 hours
C) 20 hours
D) 40 hours
Correct Answer: C
Rationale: Steady-state concentration is typically reached after approximately 4–5 half-lives.
With a half-life of 4 hours, steady-state would be achieved in approximately 20 hours (4 hours ×
5 half-lives).
---
Question 3
Which of the following factors would most significantly increase the volume of distribution of a
lipophilic drug?
A) Decreased cardiac output
B) Increased adipose tissue
C) Decreased renal function
D) Increased protein binding
Correct Answer: B
, Rationale: Lipophilic drugs distribute extensively into adipose tissue. Increased adipose tissue
provides a larger reservoir for drug storage, thereby increasing the volume of distribution.
---
Question 4
A patient with hepatic cirrhosis is prescribed a medication that undergoes extensive first-pass
metabolism. What adjustment is most appropriate?
A) Increase the dose
B) Decrease the dose
C) No dose adjustment is needed
D) Change to a topical formulation
Correct Answer: B
Rationale: Hepatic cirrhosis reduces liver function and first-pass metabolism. A lower dose is
required to achieve therapeutic drug levels and avoid toxicity.
---
Question 5
Which of the following drug classes primarily undergoes renal elimination?
A) Benzodiazepines
B) Aminoglycosides
C) Beta-blockers
D) Calcium channel blockers
Correct Answer: B
